The poor penetration of topical burn agent through burn eschar on a porcine burn model [Letter to the Editor]


Autoria(s): Wang, Xue-Qing; Hayes, Mark T.; Kempf, Margit; Cuttle, Leila; Mill, Julie; Kimble, Roy M.
Data(s)

2009

Resumo

We read with great interest the article entitled “Enhancing drugs absorption through third-degree burn wound eschar” by Manafi et al. [1]. The authors addressed the concern of poor penetration of topically applied anti-microbials through burn eschar and detailed the improvement of this penetration by penetration enhancers. Here, we would like to report the poor penetration of a topical agent into the viable deep dermal layer under burn eschar on a porcine burn model [2]. In burn treatment, a common practice is the topical application of either anti-microbial products or wound enhancing agents. While the activity of anti-microbial products is designed to fight against microbes on the wound surface but with the least toxicity to viable tissue, wound enhancing agents need to reach the viable tissue layer under the burn eschar. Many studies have reported the accelerated healing of superficial burn wounds and skin graft donor sites by the topical application of exogeneous growth factors [3]. It is well known that the efficacy of the penetration of a topical agent on intact skin mostly depends on the molecular size of the product [4] and [5]. While burn injury destroys this epidermal physiological barrier, the coagulated burn tissue layer on the burn wound surface makes it difficult for topical agents to reach viable tissue....

Identificador

http://eprints.qut.edu.au/67222/

Publicador

Elsevier

Relação

DOI:10.1016/j.burns.2008.08.022

Wang, Xue-Qing, Hayes, Mark T., Kempf, Margit, Cuttle, Leila, Mill, Julie, & Kimble, Roy M. (2009) The poor penetration of topical burn agent through burn eschar on a porcine burn model [Letter to the Editor]. Burns, 35(6), pp. 901-902.

Direitos

Copyright 2009 Elsevier

This is the author’s version of a work that was accepted for publication in Burns. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. Changes may have been made to this work since it was submitted for publication. A definitive version was subsequently published in Burns, [VOL 35, ISSUE 6, (2009)] DOI: 10.1016/j.burns.2008.08.022

Fonte

School of Biomedical Sciences; Faculty of Health; Institute of Health and Biomedical Innovation

Palavras-Chave #Administration #Cutaneous #Animals #Blood Proteins/*pharmacokinetics #Burns/*metabolism #Debridement #Disease Models #Animal #Female #Sus scrofa #alpha-2-HS-Glycoprotein
Tipo

Journal Article